Photothermal nanomaterials for theranostics of atherosclerosis and thrombosis
Source abstract
Abstract
Nonradiative therapies focusing on converting energy from light into heat (photothermal therapy, PTT) have been widely studied for the treatment of cancers. In the last years, interests in the potential therapeutic efficiency of PTT in cardiovascular diseases have grown quickly. Nonetheless, research in this field is still limited and requires further attention. One of the advantages of nanocarriers used as photothermal agents is the possibility to integrate multimodal imaging and therapeutic functions as a solution to address the current limitations in the clinic. In this review, we first explain the mechanism of nanoparticle-mediated photothermal therapy and summarize the advances in the development of inorganic, organic, and hybrid nano photothermal transduction agents (PTAs). Then we discuss the toxicity, challenges and limitations encountered in the development of phototherapy for cardiovascular diseases. The review concludes with highlighting possible solutions for improving PTT in this specific field.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. 2017
2. Arterial thrombosis–insidious, unpredictable and deadly10.1038/nm.2515 ↗
3. Heart disease and stroke statistics–2013 update: a report from the American Heart Association
4. Nielsen · 2023
5. Targeting endothelial VCAM-1 in atherosclerosis: drug discovery and development of VCAM-1-directed novel therapeutics
6. Advances in drug delivery to atherosclerosis: investigating the efficiency of different nanomaterials employed for different type of drugs
7. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis
8. Molecular biology of atherosclerosis
9. Adhesion molecules and atherogenesis10.1046/j.1365-201X.2001.00882.x ↗
10. Monocyte recruitment and foam cell formation in atherosclerosis10.1016/j.micron.2005.10.007 ↗
11. Nanomedicine as a strategy to fight thrombotic diseases10.4155/fso.15.46 ↗
12. Pathogenesis of atherosclerosis10.1016/j.jacc.2005.09.068 ↗
13. Mouse models for atherosclerosis research—which is my line?
14. Atherothrombosis-on-chip: a site-specific microfluidic model for thrombus formation and drug discovery
15. A spiky silver-iron oxide nanoparticle for highly efficient targeted photothermal therapy and multimodal imaging of thrombosis
16. Elaborately engineering a self-indicating dual-drug nanoassembly for site-specific photothermal-potentiated thrombus penetration and thrombolysis10.1002/advs.202104264 ↗
17. New developments and future challenges of nuclear medicine and molecular imaging for pulmonary embolism10.1016/j.thromres.2017.06.031 ↗
18. Imaging of occlusive thrombi in acute ischemic stroke10.1111/ijs.12435 ↗
19. Diagnosis of deep vein thrombosis10.1016/0753-3322(96)84820-7 ↗
20. Diagnosis and management of deep venous thrombosis in the emergency department
21. Deep vein thrombosis and pulmonary embolism10.1016/S0140-6736(16)30514-1 ↗
22. Invasive strategies for the treatment of pulmonary embolism. Where are we in 2020?10.1016/j.cpcardiol.2020.100650 ↗
23. Recent advances in the development of theranostic nanoparticles for cardiovascular diseases10.7150/ntno.62730 ↗
24. Recent advances in cancer therapy based on dual mode gold nanoparticles10.3390/cancers9120173 ↗
25. Chapter 5 - Nanomedicine for treatment of cardiovascular diseases and stroke
26. Dilnawaz · 2021
27. Nanoparticles for treatment of atherosclerosis: challenges of plasmonic photothermal therapy in translational studies10.2217/fca-2017-0051 ↗
28. Glimpse into the future of nanotheranostic strategies for regression of atherosclerosis through the prism of systems biomedicine: systematic review of innovations from multifunctional nanoformulations to devices on chip10.2174/2468187306666161121142756 ↗
29. Research inequality in nanomedicine
30. Smart nanotheranostics responsive to pathological stimuli
31. Organic molecule-based photothermal agents: an expanding photothermal therapy universe10.1039/C7CS00522A ↗
32. Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy10.1016/j.jare.2010.02.002 ↗
33. Iron oxide nanoparticles in photothermal therapy10.3390/molecules23071567 ↗
34. Recent progress and development on polymeric nanomaterials for photothermal therapy: a brief overview10.1039/C6TB02249A ↗
35. Nanomaterial applications in photothermal therapy for cancer10.3390/ma12050779 ↗
36. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer10.1039/C8CS00618K ↗
37. Applications of inorganic nanomaterials in photothermal therapy based on combinational cancer treatment10.2147/IJN.S239751 ↗
38. Recent advances in different modal imaging-guided photothermal therapy10.1016/j.biomaterials.2016.08.022 ↗
39. Synergistic nanomedicine by combined gene and photothermal therapy10.1016/j.addr.2015.12.018 ↗
40. Plasmonic photothermal therapy for atheroregression below Glagov threshold10.2217/fca.13.16 ↗
41. Nanomaterials as photothermal therapeutic agents10.1016/j.pmatsci.2018.07.005 ↗
42. PEGylated polydopamine-coated magnetic nanoparticles for combined targeted chemotherapy and photothermal ablation of tumour cells10.1016/j.colsurfb.2017.09.012 ↗
43. Hierarchical micro-/nanostructures from human hair for biomedical applications10.1002/adma.201800836 ↗
44. Current limitations and recent progress in nanomedicine for clinically available photodynamic therapy10.3390/biomedicines9010085 ↗
45. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy10.1111/j.1751-1097.2009.00585.x ↗
46. Features of third generation photosensitizers used in anticancer photodynamic therapy: review10.1016/j.pdpdt.2020.102091 ↗
47. Cellular uptake of nanoparticles versus small molecules: a matter of size10.1021/acs.accounts.8b00292 ↗
48. A new antibacterial nano-system based on hematoporphyrin-carboxymethyl chitosan conjugate for enhanced photostability and photodynamic activity10.1016/j.carbpol.2021.118242 ↗
49. Emerging strategies in enhancing singlet oxygen generation of nano-photosensitizers toward advanced phototherapy10.1007/s40820-022-00856-y ↗
50. Carbon dots as versatile photosensitizers for solar-driven catalysis with redox enzymes10.1021/jacs.6b10146 ↗
51. Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery10.1038/nnano.2015.342 ↗
52. Laser heating of metallic nanoparticles for photothermal ablation applications
53. Near-infrared light-responsive inorganic nanomaterials for photothermal therapy
54. Elaborately engineering a self-indicating dual-drug nanoassembly for site-specific photothermal-potentiated thrombus penetration and thrombolysis
55. Iqbal · 2021
56. Surface plasmon resonance of nanoparticles and applications in imaging10.1007/s00205-015-0928-0 ↗
57. Surface plasmon resonance in gold nanoparticles: a review10.1088/1361-648X/aa60f3 ↗
58. Wulff in a cage gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging10.1039/C8NR05203D ↗
59. A gold nanoparticles coated unclad single mode fiber-optic sensor based on localized surface plasmon resonance10.1038/s41598-023-32852-6 ↗
60. Evidence and implications of direct charge excitation as the dominant mechanism in plasmon-mediated photocatalysis10.1038/ncomms10545 ↗
61. Localised surface plasmon resonance inducing cooperative Jahn–Teller effect for crystal phase-change in a nanocrystal10.1038/s41467-023-40153-9 ↗
62. Evolution from the plasmon to exciton state in ligand-protected atomically precise gold nanoparticles10.1038/ncomms13240 ↗
63. Surface plasmon resonance based fiber optic dopamine sensor using green synthesized silver nanoparticles10.1016/j.snb.2015.10.106 ↗
64. Heat generation in plasmonic nanostructures: influence of morphology10.1063/1.3116645 ↗
65. Multifunctional gold nanorods for selective plasmonic photothermal therapy in pancreatic cancer cells using ultra-short pulse near-infrared laser irradiation10.1039/C5NR00114E ↗
66. Thermo-plasmonics: using metallic nanostructures as nano-sources of heat10.1002/lpor.201200003 ↗
67. The most effective gold nanorod size for plasmonic photothermal therapy: theory and in vitro experiments10.1021/jp409298f ↗
68. Photothermal effects of plasmonic metal nanoparticles in a fluid10.1063/1.4942623 ↗
69. Nanomaterials for treating cardiovascular diseases: a review
70. Nanomedicines for cardiovascular disease10.1038/s44161-023-00232-y ↗
71. Gold-iron oxide nanoparticle: a unique multimodal theranostic approach for thrombosis
72. Silver/iron oxide nano-popcorns for imaging and therapy10.1021/acsanm.1c01571 ↗
73. Magnetic iron sulfide nanoparticles as thrombolytic agents for magnetocaloric therapy and photothermal therapy of thrombosis10.3389/fmats.2019.00316 ↗
74. Copper sulfide nanoparticles as a photothermal switch for TRPV1 signaling to attenuate atherosclerosis10.1038/ncomms100 ↗
75. Near infrared imaging and photothermal ablation of vascular inflammation using single-walled carbon nanotubes10.1161/JAHA.112.002568 ↗
76. Dual-targeting glycol chitosan/heparin-decorated polypyrrole nanoparticle for augmented photothermal thrombolytic therapy10.1021/acsami.0c20940 ↗
77. Targeted theranostic photoactivation on atherosclerosis10.1186/s12951-021-01084-z ↗
78. SR-A-targeted nanoplatform for sequential photothermal/photodynamic ablation of activated macrophages to alleviate atherosclerosis10.1021/acsami.1c06380 ↗
79. Aminolevulinic acid with gold nanoparticles: a novel theranostic agent for atherosclerosis10.1039/C4AN02166E ↗
80. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent10.1016/j.actbio.2021.07.072 ↗
81. Tuning the distance of rattle-shaped IONP@ shell-in-shell nanoparticles for magnetically-targeted photothermal therapy in the second near-infrared window10.1021/acsami.7b14593 ↗
82. A future for hyperthermia in cancer treatment?10.1016/S0959-8049(01)00193-9 ↗
83. Targeted molecular imaging of cardiovascular diseases by iron oxide nanoparticles10.1161/ATVBAHA.120.315404 ↗
84. Gold nanorods as a theranostic platform for in vitro and in vivo imaging and photothermal therapy of inflammatory macrophages10.1039/C5NR02521D ↗
85. Diagnosis and therapy of macrophage cells using dextran-coated near-infrared responsive hollow-type gold nanoparticles10.1088/0957-4484/19/37/375105 ↗
86. Intravascular photoacoustics for image-guidance and temperature monitoring during plasmonic photothermal therapy of atherosclerotic plaques: a feasibility study10.7150/thno.7143 ↗
87. Small multifunctional nanoclusters (nanoroses) for targeted cellular imaging and therapy10.1021/nn900440e ↗
88. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast10.1016/j.biomaterials.2017.04.037 ↗
89. Novel iron oxide–cerium oxide core–shell nanoparticles as a potential theranostic material for ROS related inflammatory diseases10.1039/C8TB00022K ↗
90. Activatable magnetic resonance nanosensor as a potential imaging agent for detecting and discriminating thrombosis10.1039/C8NR05095C ↗
91. Effects of magnetic field strength and particle aggregation on relaxivity of ultra-small dual contrast iron oxide nanoparticles10.1088/2053-1591/aa96e3 ↗
92. Non-invasive imaging techniques for the differentiation of acute and chronic thrombosis10.1016/j.thromres.2019.03.009 ↗
93. Investigating the use of layered double hydroxide nanoparticles as carriers of metal oxides for theranostics of ROS-related diseases10.1021/acsabm.9b00852 ↗
94. Chitosan nanococktails containing both ceria and superparamagnetic iron oxide nanoparticles for reactive oxygen species-related theranostics10.1021/acsanm.1c00141 ↗
95. Different approaches to develop nanosensors for diagnosis of diseases10.1002/advs.202001476 ↗
96. Engineering chitosan nano-cocktail containing iron oxide and ceria: a two-in-one approach for treatment of inflammatory diseases and tracking of material delivery10.1016/j.msec.2021.112477 ↗
97. Visualizing stem cells in vivo using magnetic resonance imaging10.1002/wnan.1760 ↗
98. Spiky silver–iron oxide nanohybrid for effective dual-imaging and synergistic thermo-chemotherapy10.1021/acsami.3c04696 ↗
99. Treatment of atherosclerotic plaque: perspectives on theranostics10.1111/jphp.13092 ↗
100. Enzymatic antibody tagging: toward a universal biocompatible targeting tool10.1016/j.tcm.2012.07.004 ↗